Holista Colltech Limited (ASX:HCT)

Market Cap	27.22M +217.5%
Revenue (ttm)	5.79M +3.1%
Net Income	-948.92K
EPS	-0.00
Shares Out	367.83M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	13,000
Open	0.0740
Previous Close	0.0750
Day's Range	0.0740 - 0.0740
52-Week Range	0.0500 - 0.1100
Beta	1.29
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 5, 2026

About Holista Colltech

Holista Colltech Limited operates as a research-driven biotech company in Australia, Malaysia, and the United States. The company operates through Supplements, Ovine Collagen, Infection Control Solutions, Food Ingredients, and Corporate segments. It manufactures and wholesales dietary supplements; cosmetic grade collagen; infection control solutions; and healthy food ingredients, including low-glycemic index (GI) bread, noodles/pasta, and flatbreads, as well as low-calorie/low-GI sugar substitutes. Further, it offers GI LiTE, a premix glycemic ...

• Industry: Packaged Foods
• Sector: Consumer Staples
• CEO: Leong Loong
• Employees: 58
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: HCT

Financial Performance

In 2025, Holista Colltech's revenue was 5.79 million, an increase of 3.08% compared to the previous year's 5.61 million. Losses were -948,921, 1026.8% more than in 2024.